Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
9.3%
% of IBBQ's 204 holdings also in IBRN
50.0%
% of IBRN's 54 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 3.6% | 4.7% | 3.6% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 4.9% | 1.5% |
|
SAREPTA THERAPEUTICS INC | 1.4% | 4.8% | 1.4% |
 |
ARGENX SE ADR | 1.3% | 4.5% | 1.3% |
|
INTRA-CELLULAR THERAPIES INC | 0.7% | 4.3% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to IBRN
|
AMGEN INC | 10.0% |
|
REGENERON PHARMACEUTICALS | 8.9% |
|
VERTEX PHARMACEUTICALS INC | 8.9% |
|
GILEAD SCIENCES INC | 8.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.1% |
|
MODERNA, INC. | 5.1% |
|
ALNYLAM PHARMACEUTICALS INC | 2.1% |
|
ILLUMINA INC | 2.0% |
|
BIOMARIN PHARMACEUTICAL INC | 1.7% |
 |
SANOFI-AVENTIS-ADR | 1.5% |
IBBQ Underweight Relative to IBRN
|
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% |
|
AXONICS MODULATION TECHNOLOGIES, INC | -4.7% |
|
PTC THERAPEUTICS INC | -4.5% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |
|
SAREPTA THERAPEUTICS INC | -3.4% |
|
INTEGRA LIFESCIENCES HOLDING | -3.4% |
|
NEUROCRINE BIOSCIENCES INC | -3.3% |
 |
ALKERMES PLC | -3.3% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |